CTX-2026
CTX-2026 is a fully human antibody that binds to CD277. CTX-2026 shows an anti-tumor effect on ovarian tumor models. CTX-2026 can be used for the research of cancer[1].
Product Specifications
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ctx-2026.html
Purity
98.95
Solubility
10 mM in DMSO
Smiles
[3H][C][X2026]
Molecular Weight
(145.28 kDa)
References & Citations
[1]Payne KK, et al. BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells. Science. 2020 Aug 21;369 (6506) :942-949.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC681060-100 1x 100 µL
Chromogranin A (CGA414 + CGA/777 + CGA/798), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
PKSH032673-01 10 µg
Recombinant Human Arginase-2/ARG2 Protein (His Tag)
Sign In for Pricing
View Details PKSH032673-02 50 µg
Recombinant Human Arginase-2/ARG2 Protein (His Tag)
Sign In for Pricing
View Details 